This review covers the historical developments of the consideration th
at tryptophan may influence the induction of cancer in experimental st
udies. Studies relating to stimulatory effects, as well as to inhibito
ry effects, of tryptophan or tryptophan-related compounds are describe
d. Also the effects of pyrolysis products of tryptophan on carcinogene
sis are covered. In consideration that new L-tryptophan-related contam
inants may be involved in a recently described human disease, a descri
ption is given of the eosinophilia-myalgia syndrome, which has been at
tributed to the ingestion of L-tryptophan-containing related contamina
nts. Whether these new L-tryptophan-related contaminants alone or toge
ther with L-tryptophan may prove to be carcinogenic remains to be dete
rmined. Lastly, recent developments relating to regulatory effects of
L-tryptophan on liver metabolism are reviewed and then considered as p
ossibly playing a role in carcinogenesis.